We are live on ! Find out more
BCC

Bridge City Capital Portfolio holdings

AUM $361M
1-Year Est. Return 38.29%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+38.29%
3 Year Est. Return
+76.88%
5 Year Est. Return
+81.43%
10 Year Est. Return
AUM
$374M
AUM Growth
+$18M
Cap. Flow
-$2.07M
Cap. Flow %
-0.55%
Top 10 Hldgs %
22.43%
Holding
113
New
6
Increased
38
Reduced
57
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 30.02%
2 Healthcare 23.16%
3 Industrials 14.74%
4 Consumer Discretionary 11.81%
5 Financials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWO icon
101
iShares Russell 2000 Growth ETF
IWO
$15.1B
$317K 0.08%
989
+235
+31% +$70.9K
BMRC icon
102
Bank of Marin Bancorp
BMRC
$459M
$305K 0.08%
12,566
ELMD icon
103
Electromed
ELMD
$349M
$295K 0.08%
+12,030
New +$255K
FC icon
104
Franklin Covey
FC
$246M
$293K 0.08%
+15,080
New +$298K
PNTG icon
105
Pennant Group
PNTG
$1.36B
$249K 0.07%
+9,871
New +$242K
JYNT icon
106
The Joint Corp
JYNT
$119M
$248K 0.07%
25,979
ARAY icon
107
Accuray
ARAY
$34M
$222K 0.06%
133,156
QIPT
108
DELISTED
Quipt Home Medical
QIPT
$136K 0.04%
52,199
AMED
109
DELISTED
Amedisys
AMED
-34,455
Closed -$3.39M
BGSF icon
110
BGSF Inc
BGSF
$60M
-50,767
Closed -$323K
MTZ icon
111
MasTec
MTZ
$21.9B
-49,357
Closed -$8.41M
MYRG icon
112
MYR Group
MYRG
$5.25B
-4,712
Closed -$855K
PFGC icon
113
Performance Food Group
PFGC
$18B
-84,329
Closed -$7.38M

Similar funds

Bridge City Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Bridge City Capital held 113 positions worth $374M, up 5% from $356M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Bridge City Capital's Q3 2025 filing shows 6 new, 38 increased, 57 reduced and 5 closed positions. Its largest new stake was Krystal Biotech: 14,154 shares worth $2.5M. The largest sale was MasTec, an estimated $8.41M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Bridge City Capital's largest Q3 2025 buy was Krystal Biotech: 14,154 shares worth $2.5M.
  • Bridge City Capital added most to Pacira BioSciences in Q3 2025, an estimated $3.48M increase.
  • Bridge City Capital's biggest Q3 2025 reduction was Sterling Infrastructure, cutting an estimated $4.77M.
  • Bridge City Capital fully exited MasTec in Q3 2025, selling an estimated $8.41M.
  • Bridge City Capital's ten largest holdings make up 22% of its $374M portfolio in Q3 2025.
  • Bridge City Capital opened 6 new positions and closed 5 in Q3 2025.
  • Bridge City Capital's portfolio value rose 5% quarter-over-quarter to $374M.

Based on Bridge City Capital's 13F filing for Q3 2025, filed 12 Nov 2025.